期刊文献+

西拉普利对心房颤动犬内皮细胞功能及纤溶系统的影响

Effect of Cilazapril on endothelial cell function and fibrinolysis system in the canine atrial fibrillation models
原文传递
导出
摘要 目的研究血管紧张素转换酶抑制剂西拉普利对心房颤动(房颤)犬内皮功能和纤溶系统的影响。方法应用埋藏式高频心脏起搏器快速起搏心房建立房颤犬动物模型。实验分为未起搏组、单纯起搏组和起搏+西拉普利组。采用ISO NOP3005一氧化氮(NO)敏感电极测定心内膜NO含量;酶联免疫吸附双抗体夹心法测定血浆血管性血友病因子水平;Westernblot定量分析心房心肌纤溶酶原激活剂抑制物1(PAI1)和组织型纤溶酶原激活剂(tPA)蛋白表达;同时免疫组化检测蛋白表达位置。血浆PAI1和tPA含量采用酶联免疫吸附双抗体夹心法测定。结果西拉普利能显著增加房颤犬心内膜NO合成,降低血浆血管性血友病因子水平,同时显著减少心房肌PAI1蛋白表达和血浆PAI1含量,增加心房肌tPA蛋白表达和血浆含量。结论西拉普利能明显改善房颤犬内皮细胞功能,恢复纤溶系统平衡,可能对房颤的血栓前状态有益。 ObjectiveTo investigate the effect of cilazapril on endothelial cell function and fibrinolysis system in the canine atrial fibrillation(AF)models. MethodsAll canines were divided into three groups: (1)Control group, without atrial pacing; (2)Atrial pacing group, in which atrial fibrillation was established by rapid atrial pacing at 400 bpm for 6 weeks;(3) Atrial pacing together with cilazapril group, in which cilazapril was given before and after atrial pacing. Nitric oxide (NO) of atrial endocardium was measured with NO-specific microelectrode. The expression of plasminogen activator inhibitor-1(PAI-1) and tissue-type plasminogen activator(tPA)protein in atrium was determined by Western Blot analysis and immunohistochemical staining. Plasma levels of von Willebrand Factor (vWF), PAI-1 and tPA were analyzed by enzyme-linked immunoadsorbent assay. ResultsNO production from atrial endocardium was significantly increased in atrial pacing together with cilazapril group than atrial pacing group[(42.6±9.9)nmol/L vs(23.4±5.8)nmol/L , P<0.05], whereas the plasma levels of vWF were decreased [(75.4±12.8)% vs (125.9±20.6)%, P<0.05]. Compared to controls, the expression of atrium tPA protein in atrial pacing together with cilazapril group was significantly upregulated (4052±857 vs 1936±421, P<0.05) and PAI-1 protein was downregulated (2487±542 vs 3164±827, P<0.05). Cilazapril also significantly increased tPA antigen and decreased PAI-1 antigen in plasma. ConclusionCilazapril can favorably improve endothelial function and resume the balance of fibrinolysis system in AF, which might be of beneficial to hypercoagulated state in AF.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2005年第5期469-472,共4页 Chinese Journal of Cardiology
  • 相关文献

参考文献1

二级参考文献15

  • 1Swiatkowska M, Cierniewska-Cieslak A, Pawlowska Z, et al. Dual regulatory effects of nitric oxide on plasminogen activator inhibitor type 1 expression in endothelial cells. Eur J Biochem,2000,267: 1001-1007.
  • 2Davis ME,Cai H,Drummond GR,et al.Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways. Cir Res,2001,89:1073-1080.
  • 3Morillo CA,Klein GJ,Jones DL,et al. Chronic rapid atrial pacing: a structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation,1995,91:1588-1599.
  • 4Cai H,Li Z,Goette A,et al.Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation:potential mechanisms for atrial thrombosis and stroke.Circulation,2002,106:2854-2858.
  • 5Fukuchi M, Watanabe J, Kumagai K, et al. Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. J Am Coll Cardiol, 2001, 37:1436-1442.
  • 6Kubo-Inoue M, Egashira K, Usui M, et al. Long-term inhibition of nitric oxide synthesis increases arterial thrombogenecity in rat carotid artery. Am J Physiol Heart Circ Physiol,2002 ,282:H1478-1484.
  • 7Luscher TF,Diederich D,Siebenmann R,et al. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med,1988,319:462-467.
  • 8Davis ME, Grumbach IM, Fukai T, et al. Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kappa B binding. J Biol Chem, 2004 ,279:163-168.
  • 9Schafer K, Muller K, Hecke A,et al. Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol,2003,23:2097-2103.
  • 10Kauhanen P, Siren V, Carpen O, et al. Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure. Circulation,1997,96: 1783-1789.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部